BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular ...

Driving the future of cardiovascular diagnosis and disease management through investigations of clinical genetics and the novel application of precision medicine ...

View all available purchase options and get full access to this article.

BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study ...

The premier international journal in basic and translational cardiovascular biology and source for the most revolutionary research in the field ...

Cardiovascular disease (CVD) is the leading cause of death among women. With the recognition of disparities in cardiovascular care in women, the American Heart Association’s Go Red for Women campaign ...

Figure 1. Some of the alterations in the metabolic risk profile that have been found to be related to abdominal obesity assessed by anthropometry and later to excess visceral adiposity/ectopic fat ...

When a manuscript is ready for submission, please proceed to the manuscript submission site. Those manuscripts that are revised or ultimately accepted will be required to be formatted by the authors ...

Blogging Stroke highlights high-impact studies published in the journal Stroke. In addition to article summaries, Blogging Stroke includes interviews with authors of recently published Stroke articles ...

Because of these effects, understanding the out-of-pocket costs for SGLT-2 inhibitors is essential. However, estimates for out-of-pocket costs are limited with no nationally representative or ...